Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system

Published:2017-10 Issue: Volume:245 Page:277-284
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Nilsson Erik,Gasparini Alessandro^ORCID,Ärnlöv Johan,Xu Hairong,Henriksson Karin M.,Coresh Josef,Grams Morgan E.,Carrero Juan Jesus

Funder

AstraZeneca

Swedish Heart and Lung Foundation

Stockholm County Council

Vifor Fresenius Medical Care Renal Pharma

Martin Rind's and Westman's Foundations

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference49 articles.

1. Management of hyperkalemia: an update for the internist;Kovesdy;Am. J. Med.,2015

2. Updates in hyperkalemia: outcomes and therapeutic strategies;Kovesdy;Rev. Endocr. Metab. Disord.,2016

3. Prediction and management of hyperkalemia across the spectrum of chronic kidney disease;Lazich;Semin. Nephrol.,2014

4. Drug-induced hyperkalemia;Salem;Drug Saf.,2014

5. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators;Pitt;N. Engl. J. Med.,1999

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyperkalemia burden and treatment patterns in Chinese patients on hemodialysis: final analysis of a prospective multicenter cohort study (PRECEDE-K);Renal Failure;2024-09-09

2. Twelve hot questions in the management of hypertension in patients aged 80+ years and their answers with the help of the 2023 European Society of Hypertension Guidelines;Journal of Hypertension;2024-09-05

3. GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes;JAMA Internal Medicine;2024-08-12

4. Beta-lactam-associated hypokalemia;Journal of International Medical Research;2024-08

5. SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study;BMJ;2024-06-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3